International Clinical Trial: Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130604) titled 'Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis' on Aug. 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: InventisBio Co., Ltd

Condition: Plaque Psoriasis

Intervention: Drug: D-2570

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 26, 2025

Target Sample Size: 390

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130604

Published by HT Digital C...